Logo image of PFMT

PERFORMANT HEALTHCARE INC (PFMT) Stock Fundamental Analysis

NASDAQ:PFMT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

3.56  -0.12 (-3.26%)

After market: 3.56 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PFMT. PFMT was compared to 104 industry peers in the Health Care Providers & Services industry. While PFMT seems to be doing ok healthwise, there are quite some concerns on its profitability. PFMT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PFMT had negative earnings in the past year.
PFMT had a positive operating cash flow in the past year.
PFMT had negative earnings in each of the past 5 years.
In multiple years PFMT reported negative operating cash flow during the last 5 years.
PFMT Yearly Net Income VS EBIT VS OCF VS FCFPFMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

PFMT has a Return On Assets of -7.99%. This is in the lower half of the industry: PFMT underperforms 67.29% of its industry peers.
Looking at the Return On Equity, with a value of -10.82%, PFMT is in line with its industry, outperforming 42.06% of the companies in the same industry.
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROIC N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
PFMT Yearly ROA, ROE, ROICPFMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PFMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFMT Yearly Profit, Operating, Gross MarginsPFMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

PFMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PFMT has more shares outstanding
Compared to 5 years ago, PFMT has more shares outstanding
Compared to 1 year ago, PFMT has an improved debt to assets ratio.
PFMT Yearly Shares OutstandingPFMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
PFMT Yearly Total Debt VS Total AssetsPFMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

PFMT has an Altman-Z score of 6.53. This indicates that PFMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PFMT (6.53) is better than 89.72% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that PFMT is not too dependend on debt financing.
PFMT has a better Debt to Equity ratio (0.11) than 72.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.53
ROIC/WACCN/A
WACC9.19%
PFMT Yearly LT Debt VS Equity VS FCFPFMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.67, PFMT belongs to the best of the industry, outperforming 85.05% of the companies in the same industry.
A Quick Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.67, PFMT belongs to the best of the industry, outperforming 85.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67
PFMT Yearly Current Assets VS Current LiabilitesPFMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PFMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
Looking at the last year, PFMT shows a quite strong growth in Revenue. The Revenue has grown by 9.38% in the last year.
Measured over the past years, PFMT shows a decrease in Revenue. The Revenue has been decreasing by -6.09% on average per year.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%

3.2 Future

PFMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.89% yearly.
Based on estimates for the next years, PFMT will show a quite strong growth in Revenue. The Revenue will grow by 9.22% on average per year.
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PFMT Yearly Revenue VS EstimatesPFMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
PFMT Yearly EPS VS EstimatesPFMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PFMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PFMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFMT Price Earnings VS Forward Price EarningsPFMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

64.49% of the companies in the same industry are cheaper than PFMT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 573.95
PFMT Per share dataPFMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as PFMT's earnings are expected to grow with 14.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PFMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PFMT (12/17/2024, 9:22:18 PM)

After market: 3.56 0 (0%)

3.56

-0.12 (-3.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners76.31%
Inst Owner Change-1.07%
Ins Owners5.33%
Ins Owner Change0.35%
Market Cap278.71M
Analysts82.22
Price Target7.14 (100.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.76%
Min EPS beat(2)1.96%
Max EPS beat(2)21.57%
EPS beat(4)4
Avg EPS beat(4)85.07%
Min EPS beat(4)1.96%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)61.76%
EPS beat(12)10
Avg EPS beat(12)45.51%
EPS beat(16)14
Avg EPS beat(16)55.91%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-2.19%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)3.71%
Revenue beat(8)4
Avg Revenue beat(8)-0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.53%
Revenue beat(16)9
Avg Revenue beat(16)0.37%
PT rev (1m)0%
PT rev (3m)-8.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-147.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.31
P/FCF N/A
P/OCF 185.19
P/B 3.7
P/tB 10
EV/EBITDA 573.95
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.54%
SpS1.54
BVpS0.96
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 16.46
Cap/Depr 104.62%
Cap/Sales 5.74%
Interest Coverage N/A
Cash Conversion 309.67%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z 6.53
F-Score6
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)75.06%
Cap/Depr(5y)70.94%
Cap/Sales(3y)3.23%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.02%
OCF growth 3Y-42.97%
OCF growth 5YN/A